advertisement

WGA Rescources

11.3.3 Apraclonidine, brimonidine (10)

Showing records 1 to 10

Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine

Search within classification 11.3.3 Apraclonidine, brimonidine
61073 Brimonidine reduces TGF-beta-induced extracellular matrix synthesis in human Tenon's fibroblasts
Hong S
BMC Ophthalmology 2015; 15: 54
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Aihara M; Adachi M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61073 Brimonidine reduces TGF-beta-induced extracellular matrix synthesis in human Tenon's fibroblasts
Han SH
BMC Ophthalmology 2015; 15: 54
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Hamada N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61073 Brimonidine reduces TGF-beta-induced extracellular matrix synthesis in human Tenon's fibroblasts
Kim CY
BMC Ophthalmology 2015; 15: 54
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Honda N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61073 Brimonidine reduces TGF-beta-induced extracellular matrix synthesis in human Tenon's fibroblasts
Kim KY; Song YK
BMC Ophthalmology 2015; 15: 54
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Koseki N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61073 Brimonidine reduces TGF-beta-induced extracellular matrix synthesis in human Tenon's fibroblasts
Seong GJ
BMC Ophthalmology 2015; 15: 54
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Matsuo H; Miyata K; Otani SI; Unoki K
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486

Issue 17-1

Change Issue


advertisement

Oculus